Section Arrow
LONA.NASDAQ
- LeonaBio Inc.
Quotes are at least 15-min delayed:2026/04/17 17:13 EDT
After Hours
Last
 8.86
0 (0.00%)
Bid
8.05
Ask
9.3
High 8.86 
Low 8.86 
Volume
Regular Hours (Closed)
Last
 8.86
+0.63 (+7.65%)
Day High 
9.1444 
Prev. Close
8.23 
1-M High
14.21 
Volume 
42.04K 
Bid
8.05
Ask
9.3
Day Low
8.075 
Open
8.23 
1-M Low
Market Cap 
77.31M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 9.93 
20-SMA 9.74 
50-SMA 7.47 
52-W High 14.21 
52-W Low 2.227 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-24.70/--
Enterprise Value
77.65M
Balance Sheet
Book Value Per Share
2.96
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
TOVXTheriva Biologics Inc0.2572+0.0049+1.94%0.09PE
After Hours 0.4177 +0.1605 +62.40%
PBMPsyence Biomedical Ltd.7.6+1.73+29.47%-- 
After Hours 8.9 +1.3 +17.11%
GERNGeron Corp1.68-0.01-0.59%-- 
After Hours 1.68 0 0.00%
IBRXImmunityBio7.7+0.45+6.21%-- 
After Hours 7.73 +0.03 +0.39%
ADMAADMA Biologics11.01+0.27+2.51%17.92PE
After Hours 10.95 -0.06 -0.54%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
LeonaBio Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for high unmet medical needs. Its key drug candidates, lasofoxifene and ATH-1105, are novel, small-molecule therapies with the potential to address treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS). LeonaBio is also exploring the use of other drug candidates that enhance the neurotrophic HGF system, including ATH-1020, to improve neuronal health and function in multiple neurological diseases. In addition, it is also focused on designing and testing new early compounds directed towards novel targets for a variety of clinical applications. The company operates as a singleoperating segment, developing and commercializing therapeutics.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.